ATE349215T1 - Die verwendung von estrogen-verbindungen zur behandlung von osteoporose - Google Patents

Die verwendung von estrogen-verbindungen zur behandlung von osteoporose

Info

Publication number
ATE349215T1
ATE349215T1 AT00969591T AT00969591T ATE349215T1 AT E349215 T1 ATE349215 T1 AT E349215T1 AT 00969591 T AT00969591 T AT 00969591T AT 00969591 T AT00969591 T AT 00969591T AT E349215 T1 ATE349215 T1 AT E349215T1
Authority
AT
Austria
Prior art keywords
treat osteoporosis
estrogen compounds
estrogen
compounds
osteoporosis
Prior art date
Application number
AT00969591T
Other languages
English (en)
Inventor
Ulla Timonen
Raija Vaheri
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE349215T1 publication Critical patent/ATE349215T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00969591T 1999-10-15 2000-10-13 Die verwendung von estrogen-verbindungen zur behandlung von osteoporose ATE349215T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15950199P 1999-10-15 1999-10-15

Publications (1)

Publication Number Publication Date
ATE349215T1 true ATE349215T1 (de) 2007-01-15

Family

ID=22572821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00969591T ATE349215T1 (de) 1999-10-15 2000-10-13 Die verwendung von estrogen-verbindungen zur behandlung von osteoporose

Country Status (13)

Country Link
EP (1) EP1223940B1 (de)
JP (1) JP2003511409A (de)
KR (1) KR20020048952A (de)
AR (1) AR034100A1 (de)
AT (1) ATE349215T1 (de)
AU (1) AU778482B2 (de)
CA (1) CA2388237C (de)
CZ (1) CZ20021278A3 (de)
DE (1) DE60032621T2 (de)
HU (1) HUP0203741A3 (de)
MX (1) MXPA02003770A (de)
PL (1) PL354539A1 (de)
WO (1) WO2001026640A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125391B4 (de) * 2001-05-23 2005-01-27 Siemens Ag Vorrichtung zum Bestücken von Substraten mit elektrischen Bauelementen
JP2005504032A (ja) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92324T1 (de) * 1989-04-18 1993-08-15 Henning Berlin Gmbh Orale zubereitungsform des oestradiolvalerats.
ATE99939T1 (de) * 1990-06-14 1994-01-15 Henning Berlin Gmbh Fluessig befuellte steckkapselpraeparate.
DE4405591C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonsubstitution

Also Published As

Publication number Publication date
PL354539A1 (en) 2004-01-26
AU7926300A (en) 2001-04-23
HUP0203741A2 (hu) 2003-02-28
AR034100A1 (es) 2004-02-04
EP1223940A2 (de) 2002-07-24
CZ20021278A3 (cs) 2003-06-18
CA2388237C (en) 2010-06-01
AU778482B2 (en) 2004-12-09
DE60032621D1 (de) 2007-02-08
CA2388237A1 (en) 2001-04-19
WO2001026640A3 (en) 2001-10-18
EP1223940B1 (de) 2006-12-27
HUP0203741A3 (en) 2004-09-28
JP2003511409A (ja) 2003-03-25
DE60032621T2 (de) 2007-10-04
WO2001026640A2 (en) 2001-04-19
KR20020048952A (ko) 2002-06-24
MXPA02003770A (es) 2002-12-13

Similar Documents

Publication Publication Date Title
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE250605T1 (de) Piperidin verbindung zur behandlung von psoriasis
ATE394103T1 (de) Verwendung von rosuvastatin (zd-4522) zur behandlung von heterozygoter familiärer hypercholesterolämie
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE338552T1 (de) Verwendungen von et743 zur behandlung von krebs
ATE279386T1 (de) Retinoide zur behandlung von emphysem
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
DE60030861D1 (de) Verwendung von escitalopram zur Behandlung von generalisierten Angstzuständen
ATE337787T1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties